A clinical concern: Neisseria meningitidis as a reemerging pathogen with increased antimicrobial resistance
- PMID: 37531249
- DOI: 10.1111/ene.16019
A clinical concern: Neisseria meningitidis as a reemerging pathogen with increased antimicrobial resistance
Comment on
-
Efficacy of innovative therapies in myasthenia gravis: A systematic review, meta-analysis and network meta-analysis.Eur J Neurol. 2023 Dec;30(12):3854-3867. doi: 10.1111/ene.15872. Epub 2023 May 30. Eur J Neurol. 2023. PMID: 37204031
References
REFERENCES
-
- Saccà F, Pane C, Espinosa PE, Sormani MP, Signori A. Efficacy of innovative therapies in myasthenia gravis: a systematic review, meta-analysis and network meta-analysis. Eur J Neurol. 2023. Online ahead of print. doi:10.1111/ene.15872
-
- Girmenia C, Barcellini W, Bianchi P, et al. Management of infection in PNH patients treated with eculizumab or other complement inhibitors: unmet clinical needs. Blood Rev. 2023;58:101013. doi:10.1016/j.blre.2022.101013
-
- Rostamian M, Chegene Lorestani R, Jafari S, et al. A systematic review and meta-analysis on the antibiotic resistance of Neisseria meningitidis in the last 20 years in the world. Indian J Med Microbiol. 2022;40:323-329. doi:10.1016/j.ijmmb.2022.05.005
-
- Saito R, Nakajima J, Prah I, et al. Penicillin- and ciprofloxacin-resistant invasive Neisseria meningitidis isolates from Japan. Microbiol Spectr. 2022;10:e0062722. doi:10.1128/spectrum.00627-22
-
- Potts CC, Rodriguez-Rivera LD, Retchless AC, et al. Antimicrobial susceptibility survey of invasive Neisseria meningitidis, United States 2012−2016. J Infect Dis. 2022;225:1871-1875. doi:10.1093/infdis/jiac046
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
